Your browser doesn't support javascript.
loading
Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs.
Capalbo, Carlo; Scafetta, Giorgia; Filetti, Marco; Marchetti, Paolo; Bartolazzi, Armando.
Afiliación
  • Capalbo C; Department of Medical Oncology, Sant'Andrea University Hospital, 00189 Rome, Italy. carlo.capalbo@uniroma1.it.
  • Scafetta G; Department of Molecular Medicine Sapienza University of Rome viale Regina Elena 324, 00161 Rome, Italy. carlo.capalbo@uniroma1.it.
  • Filetti M; Department of Oncology-Pathology Sant'Andrea University Hospital, via di Grottarossa 1035, 00189 Rome, Italy. giorge@hotmail.com.
  • Marchetti P; Department of Medical Oncology, Sant'Andrea University Hospital, 00189 Rome, Italy. marco.filetti@uniroma1.it.
  • Bartolazzi A; Department of Medical Oncology, Sant'Andrea University Hospital, 00189 Rome, Italy. paolo.marchetti@uniroma1.it.
Int J Mol Sci ; 20(7)2019 Mar 31.
Article en En | MEDLINE | ID: mdl-30935099
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Carcinoma de Pulmón de Células no Pequeñas / Galectina 3 / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Middle aged Idioma: En Revista: Int J Mol Sci Año: 2019 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Carcinoma de Pulmón de Células no Pequeñas / Galectina 3 / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Middle aged Idioma: En Revista: Int J Mol Sci Año: 2019 Tipo del documento: Article País de afiliación: Italia